share_log

康希諾生物：內幕消息 喪失對上藥康希諾的控制

CANSINOBIO: INSIDE INFORMATION DECONSOLIDATION OF CANSINO SPH BIOLOGICS INC.

香港交易所 ·  Feb 2 04:50
Summary by Moomoo AI
康希諾生物於2024年2月2日宣布，因一致行動協議自動終止，導致公司不再控制上海上藥康希諾生物製藥有限公司（簡稱「上藥康希諾」）的半數以上股權或董事會席位。康希諾生物持有上藥康希諾49.8%的股份，並在其7位董事中佔有3席。此變動使得上藥康希諾不再作為康希諾生物的附屬公司，而將轉為聯營公司入賬。該變更自2024年2月2日起生效，並預計不會對康希諾生物的財務狀況和經營成果造成重大不利影響。康希諾生物提醒股東及潛在投資者在交易股份時應審慎行事。
康希諾生物於2024年2月2日宣布，因一致行動協議自動終止，導致公司不再控制上海上藥康希諾生物製藥有限公司（簡稱「上藥康希諾」）的半數以上股權或董事會席位。康希諾生物持有上藥康希諾49.8%的股份，並在其7位董事中佔有3席。此變動使得上藥康希諾不再作為康希諾生物的附屬公司，而將轉為聯營公司入賬。該變更自2024年2月2日起生效，並預計不會對康希諾生物的財務狀況和經營成果造成重大不利影響。康希諾生物提醒股東及潛在投資者在交易股份時應審慎行事。
CONXINO BIO ANNOUNCED ON FEBRUARY 2, 2024 THAT DUE TO THE AUTOMATIC TERMINATION OF THE UNANIMOUS ACTION AGREEMENT, THE COMPANY CEASES TO CONTROL MORE THAN HALF OF THE SHARES OR BOARD SEATS OF SHANGHAI PHARMACEUTICAL CONXINO BIOPHARMACEUTICAL CO., LIMITED (“KONXINO”). Conchino Bio owns 49.8% of the drug Conchino and has 3 seats on its 7 directors. This change means that the pharmaceutical company Concino will no longer be a subsidiary of Conchino Biologics and will be transferred to the joint venture. The change will take effect from February 2, 2024 and is not expected to have a significant adverse effect on the financial condition and operating results of Conchino Bios. Consino Bio reminds shareholders and potential investors to exercise caution when trading shares.
CONXINO BIO ANNOUNCED ON FEBRUARY 2, 2024 THAT DUE TO THE AUTOMATIC TERMINATION OF THE UNANIMOUS ACTION AGREEMENT, THE COMPANY CEASES TO CONTROL MORE THAN HALF OF THE SHARES OR BOARD SEATS OF SHANGHAI PHARMACEUTICAL CONXINO BIOPHARMACEUTICAL CO., LIMITED (“KONXINO”). Conchino Bio owns 49.8% of the drug Conchino and has 3 seats on its 7 directors. This change means that the pharmaceutical company Concino will no longer be a subsidiary of Conchino Biologics and will be transferred to the joint venture. The change will take effect from February 2, 2024 and is not expected to have a significant adverse effect on the financial condition and operating results of Conchino Bios. Consino Bio reminds shareholders and potential investors to exercise caution when trading shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more